Lukas Hainz

In a move that brought both widespread relief and sharp criticism across the healthcare industry, the Drug Enforcement Administration (DEA) once again extended crucial telehealth prescribing flexibilities for controlled substances, narrowly averting a crisis for countless patients dependent on

A sweeping legislative proposal in Florida, known as the "Health Care Medical Freedom Act," is poised to fundamentally reshape the relationship between patients, healthcare providers, and public health mandates across the state. The bill, filed as HB 917 by Republican Representative Jeff Holcomb,

A critical question is now reshaping how the medical community approaches patient care after a diagnosis, challenging a long-held assumption that the rules of disease prevention also apply to disease survival. For decades, research has focused intensely on identifying risk factors to help healthy

When a ransomware strike locks an Electronic Health Record or a compromised device stops care, lives are at risk. An American Hospital Association survey found that 74% of hospitals reported impacts on direct patient care following a cyberattack. Still, many organizations treat cybersecurity as

The intricate and high-stakes process of bringing new medicines to market is undergoing a profound transformation, driven not by a single breakthrough but by the steady integration of specialized technology into every facet of clinical research. What was once a field heavily reliant on manual data

The future of medicine is no longer being synthesized exclusively in a chemistry lab; it is being grown, cultivated, and programmed within the very biological systems it is designed to heal. A transformative class of treatments known as biologics is fundamentally altering the therapeutic landscape,

In a political climate often marked by division, a significant piece of bipartisan legislation has emerged to address one of the most persistent and pressing concerns for American families: the escalating cost of healthcare. Representative Brian K. Fitzpatrick, joined by a coalition of 22

Recent turmoil within the FDA has ignited a fierce debate over the future of vaccine regulation in the United States. A senior official’s internal memo, which critics describe as a break from long-standing scientific norms, has proposed a radical overhaul of how vaccines are approved and monitored.

In the intricate landscape of South Korean corporate governance, a critical legislative proposal aimed at empowering shareholders has inadvertently triggered a wave of defensive maneuvers by some of the nation's leading pharmaceutical companies. As lawmakers debate a reform that would force

Dubai is poised to become the definitive global crossroads for healthcare transformation, announcing it will host the prestigious Global Nursing, Hospitals Management and Public Health Business Event & Exhibition from April 6–8, 2026. Organized by Utilitarian Event (UE), this landmark in-person